Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 03-2002 | 12-2001 | |
| Sales | 310 | 0 | 1,650 | 1,060 | 1,180 |
| Cost of Goods | 300 | N/A | 1,510 | 790 | 860 |
| Gross Profit | 10 | N/A | 140 | 260 | 310 |
| Operating Expenses | 690 | 0 | 1,570 | 1,550 | 1,410 |
| Operating Income | -380 | N/A | -920 | -490 | -230 |
| Interest Expense | 200 | 0 | 310 | 210 | 220 |
| Other Income | -10 | 0 | -10 | -10 | -1,280 |
| Pre-tax Income | -590 | 0 | -1,240 | -710 | -1,730 |
| Net Income Continuous | -590 | N/A | -1,240 | -710 | -1,730 |
| Net Income Discontinuous | 230 | N/A | 0 | 0 | 0 |
| Net Income | $-350 | $N/A | $-1,240 | $-710 | $-1,730 |
| EBITDA(a) | $34,640 | $N/A | $-920 | $-450 | $-200 |